Ignite Creation Date:
2024-05-06 @ 4:23 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04969731
Status:
RECRUITING
Last Update Posted:
2021-11-22
First Post:
2021-07-06
Brief Title:
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-06
First Submit QC Date:
July 18 2021
Study First Post Date:
2021-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-18
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL